82
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Pharmacokinetics-based clinical management of acquired von Willebrand syndrome: a case report

, , &
Pages 9-13 | Published online: 19 Jan 2018

References

  • NicholsWLHultinMBJamesAHvon Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)Haemophilia20081417123218315614
  • CurnowJPasalicLFavaloroEJTreatment of von Willebrand diseaseSemin Thromb Hemost201642213314626838696
  • FedericiABRandJHBucciarelliPAcquired von Willebrand syndrome: data from an international registryThromb Haemost20008434534910959711
  • JakwayJLAcquired von Willebrand’s diseaseHematol Oncol Clin North Am19926140914191452520
  • FavaloroEJPasalicLCurnowJMonitoring therapy during treatment of von Willebrand diseaseSemin Thromb Hemost201743333835427472426
  • FedericiABManagement of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveysBlood Coagul Fibrinolysis200516suppl 1S17S2115849522
  • GillJCCastamanGWindygaJHemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand diseaseBlood20151262038204626239086
  • LethagenSKyrlePACastamanGHaertelSMannucciPMHAEMATEPSurgical Study Groupvon Willebrand factor/factor VIII concentrate (Haemate P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgeryJ Thromb Haemost200751420143017439628
  • FranchiniMSurgical prophylaxis in von Willebrand’s disease: a difficult balance to manageBlood Transfus20086suppl 2s33s3819105508
  • KyrlePAMinarEHirschlMHigh plasma levels of factor VIII and the risk of recurrent venous thromboembolismN Engl J Med200034345746210950667
  • FedericiABUse of intravenous immunoglobulin in patients with acquired von Willebrand syndromeHum Immunol20056642243015866707
  • Di PaolaJLethagenSGillJPresurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand’s disease (VWD) has limited value in dosing for surgeryHaemophilia20111775275821689209
  • McEneny-KingAIorioAFosterGEdgintonANThe use of pharmacokinetics in dose individualization of factor VIII in the treatment of hemophilia A. Expert Opin Drug Metab ToxicolEpub201681919